Digitisation | April 08, 2026
IndiaAI, CDSCO launch hackathon to accelerate health innovation approvals
AI challenge offers Rs 10 lakh top prize and potential ?50 lakh deployment contract; applications open till April 17
AI challenge offers Rs 10 lakh top prize and potential ?50 lakh deployment contract; applications open till April 17
New adult supplement combines 26 vitamins, minerals and botanicals to address stress, energy, immunity and cognitive wellness in one daily tablet
API maker begins circulation of second and final call money notice for partly paid-up rights shares, completing the last leg of its 2024 fundraising cycle
The India FMCG business showed a sequential recovery and is expected to post high-single digit growth
TriNetX will provide Regeneron secure, licensed access to de-identified health data from its global network of health system partners
Interchangeable biosimilars to Prolia and Xgeva target osteoporosis and cancer-related bone complications in a $5 billion U.S. market
Approval for 5 mg and 10 mg strengths, bioequivalent to Farxiga®, strengthens Lupin’s anti-diabetic portfolio in US market
Immediate U.S. launch planned for Farxiga®-equivalent diabetes drug; opportunity pegged at $10.2 billion in annual market size
Immediate U.S. launch planned for dapagliflozin-metformin ER tablets; addressable market estimated at $514 millionannually
Immediate opportunity in the $10.2 billion U.S. market as the diabetes therapy will be manufactured at Zydus’ SEZ Ahmedabad facility
Subscribe To Our Newsletter & Stay Updated
